BATURA Phase III Trial Confirms AIRSUPRA as Effective Rescue Therapy in Asthma
May 20, 2025
Statistically Significant Results Support AIRSUPRA as New Standard for As-Needed Asthma Relief
Statistically Significant Results Support AIRSUPRA as New Standard for As-Needed Asthma Relief
Baxter (NYSE: BAX)+
announced today that it launched its latest Hemopatch sealing hemostat pad.
Tandem Diabetes Care (Nasdaq:TNDM) can bring its miniature insulin pump to more customers following a new regulatory nod.
Gradient Denervation Technologies announced today that it received FDA breakthrough device designation for its denervation system.
Trax Surgical today announced it received FDA 510(k) clearance to market its Linkt Compression Staple System.
Aevice Health announced today that it received FDA 510(k) clearance for its AeviceMD smart wearable stethoscope device.
ATLANTA, May 13, 2025 /PRNewswire/ — KNoW Biological has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). This designation is an FDA program designed to expedite the review of devices and medications for serious or life-threatening conditions where there’s preliminary evidence suggesting substantial improvement over existing therapies on the market.
Wearable technologies are revolutionizing health care, but design limitations in adhesive-based personal monitors have kept them from meeting their full potential
A patient-first solution redefines comfort and accuracy in sleep disorder testing across the U.S.
Innovative high-frequency energy technology aims to revolutionize onychomycosis care with a drug-free, patient-friendly solution.